Vetter’s Opens a New Office in South Korea

The company increases its presence in Asia.

Vetter, a company known for its experience manufacturing prefilled drug delivery systems, has officially opened a new branch office in South Korea. Vetter said the new office is in Songdo, located within the country’s biologics cluster.

According to Vetter officials, strengthening its global footprint in the Asia-Pacific region has been an ongoing goal and part of their longer-term strategic plans. Vetter established itself in the region in 2014, opening a hub in Singapore. A year later, the company opened its office in Tokyo.

Vetter Managing Director Peter Soelkner, expressing his optimism said, “Today is yet another milestone for our company. This new office will allow us to directly serve both local and global companies with South Korean market interests,” he continued. “We are certain that our market presence and activities in this market will serve as an additional base and contribution for Vetter’s future global organic growth.”

vetter-opens-office-in-south-korea (1).jpg

Left to right: Mr. Michael Vetter (Strategic Market Development, Vetter), Mr. Park Yoon-bae (President, Incheon Business Information Technopark), Mr. Cho, DongAm (Vice Mayor for Political & Economic Affairs, Incheon Metropolitan City), Mr. Peter Soelkner (Managing Director, Vetter), Mrs. Chervee Ho (Director Key Account Management Asia Pacific, Vetter) and Mr. Oskar Gold (Senior Vice President Key Account Management and Marketing/Corporate Communications, Vetter).

Picture source: Vetter Pharma International GmbH

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.